Domestic stocks settled with modest gains on steady buying demand in index pivotals. The barometer index, the S&P BSE Sensex, rose 127.19 points or 0.33% at 38,672.91. The Nifty 50 index rose 53.90 points or 0.47% at 11,623.90.
Local stocks edged higher in early trade on buying demand in index pivotals. Stocks trimmed gains in morning trade after an initial upmove. Key indices hovered in positive zone in mid-morning trade. Key indices hovered in positive zone in afternoon trade. Stocks extended gains in mid-afternoon trade as European stocks rose in early trade. Indices hovered with modest gains in late trade.
The S&P BSE Mid-Cap index rose 0.99%. The S&P BSE Small-Cap index rose 0.73%. Both these indices outperformed the Sensex.
The market breadth, indicating the overall health of the market, was positive. On the BSE, 1458 shares rose and 1180 shares fell. A total of 165 shares were unchanged.
Wipro rose 0.06%. Wipro and Indian Institute of Technology, Kharagpur (IIT Kharagpur) signed a memorandum of understanding (MOU) to collaborate on high-impact, industry-focused applied research in the areas of 5G and artificial intelligence (AI). Research outcomes from this partnership will be leveraged by Wipro to develop solutions for its customers, across industry verticals. IIT Kharagpur will benefit from the commercialization of the joint research insights and Wipro's real-world industry expertise. The announcement was made after market hours yesterday, 28 March 2019.
Larsen & Toubro shed 0.05%. Larsen & Toubro has during trading hours today, 29 March 2019, announced a new strategic initiative, L&TNxt, to define the future of the organization from a fresh perspective. It has been identified as a select initiative in L&T's five-year strategic plan.
More From This Section
Lupin gained 1.99%. Lupin announced the launch of Fluocinonide Ointment USP, 0.05%, having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Fluocinonide Ointment USP, 0.05%, is the generic version of County Line Pharmaceuticals LLC's Lidex Ointment 0.05%. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. Fluocinonide Ointment USP, 0.05% (RLD: Lidex) had annual sales of approximately $15 million in the U.S (IQVIA MAT January 2019). The announcement was made after market hours yesterday, 28 March 2019.
On the economic front, the government will announce data on infrastructure output for February after market hours today, 29 March 2019.
Overseas, European and Asian shares edged higher on Friday helped by upbeat signs on U.S.-China trade talks. US stocks closed higher Thursday following reports that the U.S. and China have made progress toward a trade deal even as investors weighed data showing U.S. economic growth slowed in the fourth quarter.
In Europe, UK Prime Minister Theresa May will put her Brexit divorce deal to a vote in Parliament on Friday. May on Wednesday said she would be willing to step down if her plan to usher Britain out of the European Union was approved by Parliament.
U.S. negotiators, led by Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin, attended a working dinner Thursday night with Chinese Vice Premier Liu He, who is expected to travel to Washington next week. At a speech in Washington on Thursday, White House economic adviser Larry Kudlow said the U.S. administration was prepared to continue trade negotiations with China for weeks or even months.
In economic data, U.S. economic growth had slowed sharply in the last three months of 2018 to an annual rate of 2.2%, due to weakness in consumer spending, business investment, government spending and housing.
Powered by Capital Market - Live News